In preclinical models, the inhalation of a mixture of living Lactobacilli bacteria attenuated pulmonary inflammation and improved lung function and structure for the chronic lung diseases ...

Infants and children who have severe cases of respiratory syncytial virus (RSV) before age 2 are likely to have changes to their lung structure and function that could affect respiratory health later ...

Biological therapy was associated with significant changes in lung structure and, by extension, improved lung function in individuals with chronic obstructive pulmonary disease (COPD) and T2 ...

Researchers at the Fralin Biomedical Research Institute at VTC have identified a natural protective protein that maintains ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The ...

While the rate of adults who smoke is reportedly down to a record low of 11% and fewer adolescents are vaping, children and adults alike are leading more sedentary lifestyles that can pose a variety ...

Dr. Joshua K. Sabari explains how surgery, radiation and therapy may reduce lung capacity and shares steps survivors can take to protect their breathing health. In a recent video interview, Dr. Joshua ...

This study, published in the journal Nature Communications, determined the mechanism of this live biotherapeutic product — a powder mixture of living Lactobacilli bacteria — to reduce neutrophilic ...